MNOV: Medicinova, Inc. Company Profile & Statistics

Medicinova, Inc. Profile

About

MEDICINOVA, INC. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanesepharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. MediciNova's pipeline includes six clinical-stage compounds for the treatment of status asthmaticus, multiple sclerosis, asthma, interstitial cystitis, solid tumor cancers, Generalized Anxiety Disorder, preterm labor and urinary incontinence and twopreclinical-stage compounds for the treatment of thrombotic disorders. MediciNova will seek to monetize its other product candidates at key value inflection points.

Info & Links

CEO

Yuichi Iwaki

Headquarters

4275 EXECUTIVE SQUARE, SUITE 300
LA JOLLA, CA 92037, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

Employees

Medicinova, Inc. Statistics

Valuation Measures

Market Capitalization²

71.57M

Enterprise Value

44.24M

Enterprise Value/EBITDA(ttm)

-3.43

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

110.48

Price to Book(mrq)

1.67

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

8.06%

Operating Margin(ttm)

-1962.98%

Profit Margin(ttm)

-2035.31%

Return on Equity(ttm)

-27.28%

Return on Invested Capital(ttm)

-27.24%

Return on Assets(ttm)

-25.24%

Income Statement

Revenue(ttm)

596.60K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

48.00K

EBITDA(ttm)³

-12.90M

Net Income Available to Common(ttm)

-11.72M

Diluted EPS(ttm)

-0.23

Share Statistics

Beta (5Y Monthly)

0.63

52-Week Change

-0.74%

S&P 500 52-Week Change

21.72%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

49.22M

Dividend Yield

0.00%

Float⁴

42.33M

% Held by Insiders

14.00%

% Held by Institutions

9.90%

Balance Sheet

Total Cash(mrq)

27.33M

Total Cash Per Share(mrq)

0.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.09%

Quick Ratio(mrq)

9.09%

Book Value Per Share(mrq)

0.80

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.07

Free Cash Flow(ytd)

-3.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MNOV

Medicinova, Inc.